Psychedelic highlights | July 26 – 30 Here is a summary of the news from the…
Author: The Cannabis Stock
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…
The Parent Company Announces Voluntary Board of Director and Executive Team Lock-up Agreements
Over 35 million Shares, Representing Approximately 36% of the Issued Common Shares, Will Be Locked Up…
Braxia Scientific Provides Corporate Update and Reports Fiscal Fourth Quarter and Full-Year 2021 Financial Results
TORONTO, July 30, 2021 /CNW/ – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 496),…
Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements
Toronto, Ontario–(Newsfile Corp. – July 30, 2021) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX)…
Cronos Group Launches Delicious New Dual-Flavor Cannabis Gummies
SOURZ by Spinach™ gummies offer adult consumers a bold and juicy new cannabis edible featuring great tasting…
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology
VANCOUVER, BC, July 29, 2021 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company…
Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics
VANCOUVER, BC, July 29, 2021 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the…
Tryp Therapeutics Announces Q3 2021 Financial Results
San Diego, California–(Newsfile Corp. – July 28, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the…
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today…
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) — atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI),…
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw
Vancouver, British Columbia–(Newsfile Corp. – July 28, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)…